Role of nanoparticles in elimination of biofilm produced by pathogenic bacteria
Journal Title: Journal of Contemporary Pharmacy - Year 2022, Vol 6, Issue 1
Abstract
Biofilm is a structured conglomeration of bacteria entrenched in a polymer matrix that is self-produced and contains DNA, polysaccharide, protein, and cause chronic infections. Pseudomonas aeruginosa lung infection is one of the well stated examples of pathogenic biofilms in cystic fibrosis patients. Due to mutating nature of the pathogens high antibiotic resistance will develop that make antibiotic treatment ineffective against repeated infections that are related to indwelling medical devices. Normally it was considered that nanoparticles are not larger than 100 nm, and their development to fight infection has gained popularity over the several decades. Different types of nanoparticles were introduced to treat biofilm infections in which silver nanoparticles were considered to be more efficient than all others. Maximum zone of inhibition in case of silver nanoparticles was found to be 40 mm against S.aureus, whereas maximum zone of inhibition with ZnO nanoparticles was 16 mm against Campylobacter jejuni, while in case of selenium nanoparticles and iron oxide nanoparticles zone of inhibition was time dependent and concentration dependent respectively. The order of antibacterial activity was like that Ag-Np>ZnO>CuO>Fe2O3. In this review article we discussed different biofilm producing pathogens that were isolated from different locations in latest research and to evaluate the role of nanoparticles in eradicating these pathogenic microbes.
Authors and Affiliations
Samina Kousar, Atia Iqbal, Shafqat Rasool, Hafiz M. N. Iqbal
Preparation and characterization of magnetic nanoparticles loaded with antimicrobial agent
Background: Bacterial infections are an important cause of serious health issues worldwide. Various antibacterial drugs have been developed but they have numerous side effects. Development of drug loaded magnetic nanopar...
Formulation and evaluation of 5-fluorouracil controlled release chronotherapeutic drug delivery system (CTDDS) for colorectal cancer
Objective: As most of the drugs disintegrate and dissolve in stomach before reaching the target site and to substitute intravenous (IV) route based chrono modulated chemotherapy, oral colon target drug delivery system wa...
SCN1A gene mutation: A rising cause of human epilepsy syndrome
Epilepsy is found to be very common neurological disorder; it covers a wide range of abnormalities lying within brain. Generation of electrical activity of brain that is action potential and then its proper propagation i...
Formulation and evaluation of sustained release domperidone hydrochloride transdermal patches to treat motion sickness
Objective: Transdermal route of drug delivery is superior than oral route because it avoids first pass effect, ensures better patient compliance, reduce dosing frequency especially in extended-release formulation and is...
Formulation development and characterization of famotidine dry suspension for oral use
Famotidine an H2 receptor blocker is generally used to treat ulcers of stomach and intestine. Famotidine is available in liquid suspension that is unstable during shelf life. Degradation of the drug as well as bad smell...